- Article
- Open access
- Published:
- Rajalakshimi Vasudevan1,
- J. Narayanan2,
- Afaf Aldahish1,
- Ahmad Mohammed Asiri3,
- Abdullah Mohammed Assiri4,
- Omar Ahmed M. Asiri3,
- Ali Abduh Mashni3,
- Kenz Mudhalvan2,
- M. Arjun Gokulan2,
- S. Nirenjen2,
- V. Chitra2 &
- …
- Praveen Devanandan5
Scientific Reports , Article number: (2026) Cite this article
We are providing an unedited version of this manuscript to give early access to its findings. Before final publication, the manuscript will undergo further editing. Please note there may be errors present which affect the content, and all legal disclaimers apply.
Subjects
Abstract
Wound healing is a vital biological process that restores damaged tissue. In diabetes, this process slows down due to chronic inflammation and oxidative stress. Brucine, a natural compound from Nux vomica, is known for its anti-inflammatory and antioxidant actions and its ability to promote fibroblast growth. However, its poor solubility and toxicity limit its clinical use. To address these issues, a nanoemulgel formulation was developed to improve the delivery and wound-healing effectiveness of brucine. The study aimed to develop and evaluate a brucine-loaded nanoemulgel for wound healing. The objectives were to (i) study molecular interactions of brucine with wound-healing proteins using in-silico analysis, (ii) prepare and characterize the nanoemulgel, and (iii) test its wound-healing ability in diabetic rats. Molecular docking was performed using AutoDock 4.1 to predict brucine’s binding with proteins involved in fibroblast proliferation and tissue repair. The nanoemulgel was prepared by incorporating brucine-loaded nanoemulsion into a hydrogel base. Its drug release, skin permeation, and stability were tested using standard laboratory techniques. Wound healing was evaluated in streptozotocin-induced diabetic rats by measuring wound closure over 14 days and analyzing tissue samples microscopically. Docking results showed strong binding of brucine with fibroblast growth factor receptor (FGFR, − 9.63 kcal/mol) and epidermal growth factor receptor (EGFR, − 9.17 kcal/mol), indicating its potential to stimulate cell growth and repair. The nanoemulgel showed 1.8-fold higher drug permeation and controlled release up to 12 h compared to plain gel. In diabetic rats, wounds treated with brucine nanoemulgel showed 80% closure by day 14, compared to 65% with standard treatment and 40% in untreated controls. Histopathology confirmed better collagen formation, fibroblast proliferation, and reduced inflammation. The brucine-loaded nanoemulgel improved drug delivery and significantly accelerated diabetic wound healing. It enhanced fibroblast activity and tissue repair while minimizing inflammation. This nanoformulation offers a promising topical strategy for chronic wound management, warranting further stability and clinical studies.
Data availability
The datasets used and/or analysed during the current study available from the corresponding author on reasonable request.
References
-
Nguyen, A. V. & Soulika, A. M. The dynamics of the skin’s immune system. Int. J. Mol. Sci. 20, 1811 (2019).
-
Aldahish, A. et al. Silk fibroin nanofibers: Advancements in bioactive dressings through electrospinning technology for diabetic wound healing. Pharmaceuticals 17, 1305 (2024).
-
Nirenjen, S. & Narayanan, J. Computational profiling and pharmacokinetic modelling of Febuxostat: Evaluating its potential as a therapeutic agent for diabetic wound healing. Biochim Biophysica Acta (BBA) General Subjects 1869, 130735 (2025).
-
Shanmugasundaram, N. & Jayasankar, N. In silico profiling and pharmacokinetic modelling of olivetol: Evaluating its potential as a therapeutic agent for diabetic wound healing. Curr. Drug Discov. Technol. 22, (2025).
-
Blanco-Fernandez, B., Castaño, O., Mateos-Timoneda, M. Á., Engel, E. & Pérez-Amodio, S. Nanotechnology approaches in chronic wound healing. Adv. Wound Care (New Rochelle) 10, 234–256 (2021).
-
Pang, Q., Jiang, Z., Wu, K., Hou, R. & Zhu, Y. Nanomaterials-based wound dressing for advanced management of infected wound. Antibiotics (Basel) 12, (2023).
-
Lu, L. et al. Brucine: A review of phytochemistry, pharmacology, and toxicology. Front. Pharmacol. 11, 377 (2020).
-
Donthi, M. R. et al. Nanoemulgel: A novel nano carrier as a tool for topical drug delivery. Pharmaceutics 15, (2023).
-
Chhabra, J. et al. Potential of nanoemulsions for accelerated wound healing: innovative strategies. Int. J. Surg. 109, 2365–2377 (2023).
-
Sghier, K., Mur, M., Veiga, F., Paiva-Santos, A. C. & Pires, P. C. Novel therapeutic hybrid systems using hydrogels and nanotechnology: A focus on nanoemulgels for the treatment of skin diseases. Gels 10, (2024).
-
Mavra, A., Petrou, C. C. & Vlasiou, M. C. Ligand and structure-based virtual screening in combination, to evaluate small organic molecules as inhibitors for the xiap anti-apoptotic protein: The xanthohumol hypothesis. Molecules 27, (2022).
-
Seeger, M. A. & Paller, A. S. The roles of growth factors in keratinocyte migration. Adv. Wound Care (New Rochelle) 4, 213–224 (2015).
-
Yun, Y.-R. et al. Fibroblast growth factors: Biology, function, and application for tissue regeneration. J. Tissue Eng. 1, (2010).
-
Johnson, B. Z., Stevenson, A. W., Prêle, C. M., Fear, M. W. & Wood, F. M. The role of IL-6 in skin fibrosis and cutaneous wound healing. Biomedicines 8, 101 (2020).
-
Sadagurski, M. et al. Insulin-like growth factor 1 receptor signaling regulates skin development and inhibits skin keratinocyte differentiation. Mol. Cell Biol. 26, 2675–2687 (2006).
-
Midgley, A. C. et al. Transforming growth factor-β1 (TGF-β1)-stimulated fibroblast to myofibroblast differentiation is mediated by hyaluronan (HA)-facilitated epidermal growth factor receptor (EGFR) and CD44 co-localization in lipid rafts. J. Biol. Chem. 288, 14824–14838 (2013).
-
Johnson, K. E. & Wilgus, T. A. Vascular endothelial growth factor and angiogenesis in the regulation of cutaneous wound repair. Adv. Wound Care (New Rochelle) 3, 647–661 (2014).
-
Cabral-Pacheco, G. A. et al. The roles of matrix metalloproteinases and their inhibitors in human diseases. Int. J. Mol. Sci. 21, (2020).
-
Reshma, A. et al. Anti-obesity effects of olivetol in adult zebrafish model induced by short-term high-fat diet. Sci. Rep. 13, 18449 (2023).
-
Daina, A., Michielin, O. & Zoete, V. SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep. 7, 42717 (2017).
-
Sainy, J., Atneriya, U., Kori, J. I. & Maheshwari, R. Development of an aloe vera-based emulgel for the topical delivery of desoximetasone. Turk. J. Pharm. Sci. 18, 465–475 (2021).
-
Abdallah, M. et al. Development and evaluation of nano-vesicular emulsion-based gel as a promising approach for dermal atorvastatin delivery against inflammation. Int. J. Nanomed. 19, 11415–11432 (2024).
-
Khan, B. A. et al. Fabrication and characterizations of pharmaceutical emulgel co-loaded with naproxen-eugenol for improved analgesic and anti-inflammatory effects. Gels 8, 608 (2022).
-
Danaei, M. et al. Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 10, 57 (2018).
-
Badawy, M. E. I., Saad, A.-F.S.A., Tayeb, E.-S.H.M., Mohammed, S. A. & Abd-Elnabi, A. D. Optimization and characterization of the formation of oil-in-water diazinon nanoemulsions: Modeling and influence of the oil phase, surfactant and sonication. J. Environ. Sci. Health B 52, 896–911 (2017).
-
Shu, G. et al. Brucine, an alkaloid from seeds of Strychnos nux-vomica Linn., represses hepatocellular carcinoma cell migration and metastasis: The role of hypoxia inducible factor 1 pathway. Toxicol. Lett. 222, 91–101 (2013).
-
Deng, L. et al. The role of oxidative stress and antioxidants in diabetic wound healing. Oxid. Med. Cell Longev. 2021, (2021).
-
Jain, B. et al. Exploring brucine alkaloid: A comprehensive review on pharmacology, therapeutic applications, toxicity, extraction and purification techniques. Phytomed. Plus 3, 100490 (2023).
-
Bahloul, B. et al. Development and investigation of a nanoemulgel formulated from Tunisian Opuntia ficus-indica L. seed oil for enhanced wound healing activity. Gels 10, 582 (2024).
-
Dokla, E. M. E. et al. Nanoemulgel formulation of a benzimidazole derivative for wound healing. J. Drug Deliv. Sci. Technol. 90, 105121 (2023).
-
Morsy, M. A. et al. Preparation and evaluation of atorvastatin-loaded nanoemulgel on wound-healing efficacy. Pharmaceutics 11, 609 (2019).
Acknowledgements
The authors acknowledged to the Deanship of Research and Graduate studies at King Khalid University for funding this work through a large Research Project under grant number”RGP2/443/46″. The authors are thankful to the Management of SRM College of Pharmacy, Faculty of Medicine and Health Sciences, SRM Institute of Science and Technology and St. Peters Institute of Pharmaceutical Sciences for their Support towards the research work
Funding
Open access funding provided by SRM Institute of Science and Technology for SRMIST – Medical & Health Sciences. The authors extend their appreciation to the Deanship of Research and Graduate studies at King Khalid University for funding this work through a large Research Project under grant number “RGP2/443/46”.
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethics approval and consent to participate
This study is reported in accordance with the ARRIVE guidelines and this study was conducted following ethical guidelines and received approval from the Institutional Animal Ethics Committee under the approval number IAEC/310/2023.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc-nd/4.0/.
About this article
Cite this article
Vasudevan, R., Narayanan, J., Aldahish, A. et al. Pharmacological evaluation of a Brucine-loaded nanoemulgel for enhanced wound healing through in-silico and in-vivo investigations. Sci Rep (2026). https://doi.org/10.1038/s41598-026-39194-z
-
Received:
-
Accepted:
-
Published:
-
DOI: https://doi.org/10.1038/s41598-026-39194-z
